Together, these studies delineate a comprehensive picture wherein MYC orchestrates multiple adaptive processes including metabolic reprogramming, DNA replication, and ER stress responses that converge to promote tumor growth, progression, and treatment resistance, particularly in aging gliomas. This evidence concerns the gene MYC and central nervous system cancer.